Molecular Pharming Market Demand, Size and Competitive Analysis | TechSci Research

Global Molecular Pharming Market was valued at USD 1.58 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.74% through 2029. <table><tr><td>Pages</td><td>180</td></tr> <tr><td>Market Size</td><td>2023: USD 1.58 Billion</td></tr> <tr><td>Forecast Market Size</td><td> 2029: USD 1.91 Billion</td></tr> <tr><td>CAGR</td><td>2024-2029: 7.74%</td></tr> <tr><td>Fastest Growing Segment</td><td>Biotechnology & Pharmaceutical Companies</td></tr> <tr><td>Largest Market</td><td>North America</td></tr> <tr><td>Key Players</td><td>1.Agrenvec S.L2.Diamante SRL3.Leaf Systems International Limited4.Medicago Inc5.Meristem Therapeutics S.A.6.Moolec Science SA7.ORF Genetics8.Pfizer, Inc.9.ProdiGene Inc10.Protalix Biotherapeutics, Inc.</td></tr> </table>

全球分子制药市场规模于2023年达到15.8亿美元，预计在预测期内将实现显著增长，复合年增长率(CAGR)将达到7.74%，预计到2029年将达到19.1亿美元。

<table>
<tr><td>页数</td><td>180</td></tr>
<tr><td>市场规模</td><td>2023年：15.8亿美元</td></tr>
<tr><td>预测市场规模</td><td>2029年：19.1亿美元</td></tr>
<tr><td>复合年增长率(CAGR)</td><td>2024-2029年：7.74%</td></tr>
<tr><td>增长最快的细分市场</td><td>生物技术及制药公司</td></tr>
<tr><td>最大市场</td><td>北美</td></tr>
<tr><td>主要参与者</td><td>1. Agrenvec S.L 2. Diamante SRL 3. Leaf Systems International Limited 4. Medicago Inc 5. Meristem Therapeutics S.A. 6. Moolec Science SA 7. ORF Genetics 8. Pfizer, Inc. 9. ProdiGene Inc 10. Protalix Biotherapeutics, Inc.</td></tr>
</table>